New Era Webinars’ Post

ASCO 2024 Annual Meeting is over! 8 global pharmaceutical companies sent 2000+ commercial and medical reps onsite to this important congress equipped with SpotMe Life Sciences' Congress Field Force Hub app. SpotMe Life Sciences played a critical role in managing the logistical complexities of ASCO: ✔️ Provided pre-reads & pre-ASCO meeting coordination to ensure strategic alignment ✔️ Provided key logistical information, including badge pickup, travel, lodging, booth setup & rotation ✔️ Delivered customized agendas for the entire ASCO schedule, company sessions, competitor sessions & HCP meetings ✔️ Provided interactive maps for easy navigation of the venue, including booths & meeting rooms ✔️ Coordinated side events & satellite symposia ✔️ Sent scheduled notifications for team coordination ✔️ Enabled internal communication ✔️ Gathered competitive insights through interactive forms ✔️ Facilitated KOL engagement Throughout ASCO 2024, we saw thousands of HCP engagements & launched several new campaigns. These efforts strengthened the perception of our client portfolios & strengthened their positions in oncology R&D & commercialization. Here are three of the most interesting uses of SpotMe Life Sciences we observed at ASCO 2024: 1️⃣ A top 10 global pharma company used SpotMe Life Sciences' gamification capabilities with leaderboards & awards to drive engagement with their field force during the congress. 300+ reps participated in this race! 2️⃣ A top 50 global pharma company used SpotMe Life Sciences to coordinate ASCO all-hands team meetings to align goals for all attending teams, including a goal of 750+ KOL engagements during ASCO 2024 & to gather insights on their top 4 competitors attending ASCO 2024 using the SpotMe Life Sciences' Field Force Hub. 3️⃣ A top 30 pharma company used SpotMe Life Sciences to coordinate 300+ HCP meetings during ASCO 2024 with a 40% time savings compared to last year's DYI meeting booking stack built on Microsoft Forms, Excel & Outlook. All of these meetings were available in reps’ mobile app agendas with automated reminder notifications. Engagements recorded in customer’s CRM records! We are proud of the impact we made at ASCO 2024, helping to coordinate onsite congress logistics & streamline HCP engagement. We look forward to continuing to support our customers with our Congress Excellence Suite offering at the upcoming medical congresses this year. Next stop: EHA 2024 in Madrid! #ASCO24 #Healthcare #Pharmaceuticals #Congress #LifeSciences #PharmaEvents

Reflecting on a great first day at Dynamic Global Events (DGE) Next Gen MSL Summit. Two things jumped out at me… One I will share here. The other at another time. First. Great panel from Suzzanne Tairu, PharmD from AbbVie, Chad Fellers of Alnylam Pharmaceuticals and led by Ralph Rewers with Gilead Sciences on the importance of emotional intelligence. Powerful stories on how empathy and being in tune with signals can lead to game changing engagement. An MSL sensed things were not right with the HCP in a long anticipated, long prepared for meeting. So instead of powering through their content and requisite presentation, the MSL asked if the doc was ok and suggested that perhaps she would rather reschedule. Turned out the HCP was not OK in that moment in time. That kindness changed the relationship going forward. That individual and brand was instantly elevated in the eyes of the HCP as a trusted partner who cared about more than a script. I bet many reading this have similar stories. Sometimes it’s what is not logged in CRM or tracked on call logs that make the power of being human immeasurable. Thanks for a thoughtful provoking session and day. More from Philly later… #pharmasales #pharmamarketing #hcpengagement

WE Matter – that was the message at Pfizer’s joint Western and Eastern European clusters meeting last week. And – thanks to our excellent organizing committee, inspiring speakers and dedicated teams – I’m sure everybody left the meeting feeling visible, valued and inspired to take on 2024. Why do I say that? Well between us, we cover 34 countries across Europe – so many healthcare professionals and countless patients rely on our teams to deliver healthcare solutions in what can sometimes be a challenging environment. But, as the saying goes, “a problem shared is a problem halved” and by coming together – to identify the common challenges (and opportunities!) – we can work as one team to find solutions. Thank you once again to my friend Massimo Visentin for the great partnership. As a leader, there is nothing more strengthening than seeing people’s delighted faces, hearing the fizz of conversation and laughter and feeling the ripple of energy as colleagues come together in person. For Western and Eastern Europe, Pfizer’s #175th year now feels like it has truly begun. The work we do matters to society. The people who shape and deliver that work really matter. #Pfizercolleague #Pfizerproud

Great article Daye Bexley! We appreciate your authentic leadership and how you prioritize building trust and collaboration. Establishing trust with our customers allows us the opportunity to partner and uncover solutions that ultimately benefit patient access!

You are not alone!   Last week I hosted an agency-only meeting of the PM Society’s Industry-Agency Relationships Interest Group with co-lead Stephen Page. 12 agencies were represented, some larger networks, most smaller and independent. The question – what’s life like running healthcare comms agencies at the moment? The answer – some significant and worrying trends, but also a few green shoots that could be pointers for the future.    People on the ground, industry procurement, marketing and agency teams are not only feeling the strain, but showing it in their behaviours; Ghosting because they’re afraid of breaking relationships, having to renege on purchase orders, and pitches that evaporate despite the financial commitment made on both sides.    Worse is the direct impact on the quality of the dialogue with healthcare professionals and therefore derailing our purpose and mission: producing positive outcomes for both patients and investors.   The industry has always relied on its very capable marketing and medical affairs teams and their relationships with skilled agency communicators for disease awareness, medical education and awareness of new therapies. It is significant that Veeva has cited that 77% of all the content currently being produced for HCPs is not being read. Something is not right.   The irony is that over the last year, we’ve seen huge progress in vaccine development, cancer treatments, obesity management, and rare diseases, as well as new treatments for conditions like Alzheimer’s.    It is the value problem that persists. Consequently, every cost on the P&L is being examined and it is all too easy to focus on marketing and medical affairs, forgetting that this is the interface with the HCPs – the bit that needs to thrive – if there are to be better outcomes for investors and most importantly, patients.   In our meeting, just one member of the group talked about some progressive conversations with several pharma procurement colleagues; Overall however, the messages were disheartening. And for us, the worst aspect was the degree of desperation that has crept into conversations between industry procurement, marketing, medical affairs and their agency partners, all hardworking and expert people focused on the same mission: better outcomes for patients.    So, those green shoots? The synergy that has existed between so many capable industry and agency people has taken a few knocks and many of the individuals involved are feeling close to breaking. So, you are not alone. But while all good things come to an end, it is always followed by the next adventure and challenge.   The mission remains the same: producing positive outcomes for both patients and investors. So, we’d ask anyone experiencing the drama of the accelerating change facing the sector, to get involved and help us at the PM Society define how we all remain relevant and get back to adding the value that is so very dearly needed by patient populations around the world.

I’m pleased to announce that my new article: ‘The role of market access leaders in driving access to innovative therapies’ is featured in Modern Healthcare this month. At Sanofi, every decision we make is driven by our purpose to improve the lives of people diagnosed with disease. The Specialty Care Market Access (SCMA) team plays an important role in achieving this aim, serving as the crucial interface between brand teams and our delivery partners. To design the frameworks and facilitate the connections that drive access to therapies, I prioritize three areas as part of my leadership approach: 1. Building trust and collaboration 2. Improving our engagement with customers 3. Investing in innovative pathways   Read my article here to learn more about how SCMA continues to innovate to ensure improved access across the US: The role of market access leaders in driving access to innovative therapies | Modern Healthcare. #innovation #marketaccess #collaboration #SCMA

Please read this brief but important article by Daye Bexley on driving market access built on the foundation on trust and collaboration.

REMINDER: Advantage pricing ends tomorrow, register today to secure your spot! Act now to save $100. Use promo code "SM2024" when you register.* We have a limited number of $149 passes available for Corporate Meeting Planners, but they are going fast! Register by November 15 to save $100 - that's a two day ticket for $49! Use promo code "SM2024" when you register.* (To qualify, you must be a direct employee of a Healthcare, Life Sciences, Pharma, Medical Device, or Biotech Company.) **All registrations subject to review by the thINc team. Promo codes not applicable for Standard Rates. Discount codes are only applicable to NEW registrations. #thINcMedMeetings #MedMeetings #PharmaMeetings #MeetingProfs #EventProfs #meetingplanners #LifeSciences #eventplanner #b2bevents #PharmaMeetings #MedicalEvents #EventPlanning

Celebrating One Year of Medw1se !! "Surround yourself with people that are smarter than you, give them everything they need to grow, and your business will thrive." – Richard Branson "I agree with Richard." - Matt Britland As we celebrate our one-year anniversary at MedWise, this quote resonates deeply with our journey. Over the past year, we have grown, learned, and made remarkable strides in our mission to translate science and empower minds, aiming to optimise the Quality Use of Medicines and enhance health outcomes. Our journey has been fuelled by a team of dedicated professionals who embody the spirit of excellence and innovation. Our team, with over 120 years of combined experience, comprises experts from various fields, including medical affairs, patient affairs, communications, clinical trials, and learning and development. Each member brings unique insights and experiences, creating a dynamic and collaborative environment that drives our success. From pharmaceutical and biotech firms to CROs, patient groups, HCP's , and NFP organisations, our clients benefit from our comprehensive range of services tailored to meet their specific needs. Meet the MedWise Team: Medical Affairs: We ensure that scientific and clinical knowledge is effectively translated into practice for patients. We work closely with our clients to support the lifecycle of diagnostics and medicines, from clinical trials to full launches. Medical Insights: Leveraging data and analytics, we provide actionable intelligence that informs decision-making and strategy development. Patient Affairs: We prioritize patient engagement and advocacy, ensuring that patient perspectives are integrated into every stage of drug development and commercialisation. Learning and Development: We offer bespoke training programs that empower medical affairs professionals with the knowledge and skills they need to excel and be the best medical affairs department based on learned best practice Matthew Britland Dianne Gill Christina Koniaras Huey Wen Lee, PhD Sara McLaughlin-Barrett Melissa Blake MedWise Consulting As we reflect on our journey, we are also excited about the future. Our strategic objectives for 2024-2025 include expanding our client base, maturing our service offerings, and continuing to innovate in the field of medical and patient affairs. We have some BIG announcements coming this year. Personally, this has been the hardest, most challenging, and most epically rewarding year of my professional life. I want to extend my heartfelt thanks to my incredible team, my supportive family, friends, and all those people whose ears I bent along the way – it has truly been a rollercoaster. We are incredibly proud of what we have accomplished in our first year and are excited to build on this foundation as we move forward. Thank you to our clients, partners, and team for an incredible first year. We look forward to many more years of collaboration, innovation, and excellence.

🌍🌍 𝐉𝐨𝐢𝐧 𝐔𝐬 𝐚𝐭 𝐭𝐡𝐞 8𝐭𝐡 𝐍𝐨𝐫𝐝𝐢𝐜-𝐁𝐚𝐥𝐭𝐢𝐜 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞! The 8th Nordic-Baltic Clinical Trials Conference is taking place on October 30-31, 2024, in Helsinki. This event brings together key stakeholders from the clinical trials community to discuss how we can enhance clinical research in the Nordic and Baltic regions – and Kirsten Bødker, Head of Business Relations at Trial Nation will be there to share a Danish perspective on the topic. The Nordics have long been recognised for our robust healthcare systems and innovative research capabilities. Organisations like Trial Nation, NorTrials and Kliniska Studier Sverige play crucial roles in promoting collaboration across borders, fostering an environment where clinical trials can thrive. What can you expect at the conference? • Insights on the latest EU initiatives aimed at boosting clinical trial competitiveness, such as ACT EU and cross border clinical trials. • Discussions on decentralized clinical trials and harmonizing ethics across countries. • Presentation on national strategies from Finland, Denmark, Norway, and Sweden, showcasing best practices and collaboration opportunities in the clinical trial setting. • Panel discussions on how to translate national initiatives into impactful Nordic strategies. Whether you are a researcher, a healthcare professional, or a policymaker, this conference is a great opportunity to connect and collaborate on clinical trials in our region. Link to more information about the conference here: https://lnkd.in/dzeuFQ3w